USA remote
Director, CMC Regulatory
About this role
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients. The Opportunity: The Director, CMC Regulatory is responsible for developing, driving, and executing CMC regulatory strategies for products advancing through clinical development and marketing authorization. This role combines strategic leadership with hands-on submission delivery to support global clinical trial applications, registration, commercial readiness, and lifecycle management.
Responsibilities: Serve as the CMC Regulatory program lead to develop and execute global CMC regulatory strategies from clinical development through marketing authorization and lifecycle management, aligning regulatory activities and submission plans with program milestones and business objectives. Lead the preparation, review, and maintenance of scientifically sound, high-quality global CMC dossiers across all development stages, ensuring compliance with applicable regulatory requirements and timely submissions.
Participate in CMC-related Health Authority interactions, including developing meeting strategies, preparing briefing documents, and responding to Agency queries. Collaborate with CMC and Quality teams to support inspection readiness and fulfill regulatory commitments. Support post-approval CMC regulatory activities, including assessing CMC changes, determining reporting requirements and supporting data needs, and developing and executing submission strategies.